Purchased Funds Definition & Meaning | Financial Term | CSIMarket

Purchased Funds

Financial Term

Purchased Funds, also known as third-party funds, refer to investment funds that are managed by a third-party company or individual and sold to investors by a financial institution or advisor. These funds are designed to provide diversification, professional management, and convenience to investors who wish to access a wide range of securities but lack the expertise or resources to create and manage a portfolio on their own.

Purchased Funds can be classified into different types, including mutual funds, exchange-traded funds (ETFs), and closed-end funds. Mutual funds are investment funds with pools of money from many different investors, which are managed and invested in various securities in accordance with the fund*s objectives. ETFs, on the other hand, are investment funds that are traded on stock exchanges, and their shares can be bought and sold like any other stock. Closed-end funds are similar to mutual funds, but their shares are not redeemable on demand, and they trade on stock exchanges like ETFs.

Purchased Funds are widely used in the financial industry as a means of diversifying client portfolios and reducing investment risk. Financial advisors and institutions use these funds to offer a broad range of investment strategies to their clients, enabling investors to access a diversified mix of asset classes, regions, and sectors at a relatively low cost.

In conclusion, Purchased Funds are an important part of the financial industry, serving as a convenient and cost-effective means of accessing diversified investment portfolios. These funds offer investors access to a wide range of securities, managed by professional fund managers, enabling them to diversify their portfolios, reduce risk and achieve long-term investment goals.


More Glossary Terms Beginning with P
  • Paediatric Exclusivity
    means, in the US, a six-month period of exclusivity to market a drug which is awarded by the FDA in return for certain paediatric clinical studies using that drug. This six-month period runs from the date of relevant patent expiry.
    Health Care Term Letter: P
  • Paid Development Method
    An actuarial method to estimate ultimate losses for a given cohort of claims such as an accident year/product line component. If the paid-to-date losses are then subtracted from the estimated ultimate losses, the result is an indication of the unpaid losses. The basic premise of the method is that cumulative paid losses for a given cohort of claims will grow in a stable, predictable pattern from y
    Insurance Term Letter: P
  • Panelboards
    Oriented strand board, particleboard, medium density fibreboard and plywood. Operating Statistics
    Manufacturing Term Letter: P
  • Partial Remission PR
    A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.
    Health Care Term Letter: P
  • Particleboard
    A panelboard produced by chemically bonding clean sawdust, small wood particles and recycled wood fibre under heat and pressure. Forestry & Wood Products Industry Operating Statistics
    Manufacturing Term Letter: P
  • Particulate Matter
    Total suspended particulate. A measure of the solid particles (wood, process dust and smoke) found in air emissions.
    Manufacturing Term Letter: P
  • Particulates
    Tiny particles of a substance.
    Manufacturing Term Letter: P
  • Passenger Load Factor
    Represents the total number of seats sold as a percentage of total seat capacity on all sectors flown. Airline Industry
    Transportation Term Letter: P
  • Passenger Mile Yield
    The amount of passenger revenue earned per revenue passenger mile during a reporting period Airline Industry
    Transportation Term Letter: P
  • Passenger revenue yield per Mile Average Yield per RPM
    Represents the average scheduled passenger fare revenue for each revenue passenger mile (RPM), or each mile a scheduled revenue passenger is flown. Airline Industry
    Transportation Term Letter: P
  • Passive Immunotherapy
    Immunologically active material transferred into the patient as a passive recipient. Monoclonal antibodies are considered Passive Immunotherapy since antibodies are generated outside the body and given to the patient
    Health Care Term Letter: P
  • Patent Term Extension
    means an extension of up to five years in the term of a US patent relating to a drug which compensates for delays in marketing resulting from the need to obtain FDA approval.
    Health Care Term Letter: P